According to @StockMKTNewz, CNBC reports that Amazon AMZN said it now offers Novo Nordisk NVO Wegovy weight-loss drug through its Amazon Pharmacy digital service. Source: CNBC. Wegovy is an FDA-approved GLP-1 therapy for chronic weight management, underscoring its role within the obesity drug category tracked by healthcare equity traders. Source: U.S. Food and Drug Administration. The CNBC report did not indicate any direct cryptocurrency market impact from this rollout, suggesting no immediate crypto-market catalyst from the development. Source: CNBC.

According to Evan (@StockMKTNewz), Amazon $AMZN has announced two major updates aimed at simplifying medication management for millions of US customers, notably allowing Medicare Part D beneficiaries to access PillPack from Amazon Pharmacy for pre-sorted medication. This expansion is expected to strengthen Amazon's position in the digital healthcare sector, increasing transaction volumes and data flows that are relevant to blockchain-based health data solutions. Crypto markets may see increased interest in healthcare tokenization projects and cross-sector partnerships as Amazon's move highlights the growing intersection between health services and digital infrastructure (Source: Evan @StockMKTNewz, June 3, 2025).